written by reader Wall Street Daily Quark and DARPA

By modernrock, May 31, 2015

Surprised no one has put this one in discussion. Think-o-lator comes up with EYES.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
May 31, 2015 5:16 pm

EYES-Great sleuthing MRTV!
Company Profile

Second Sight Medical Products, Inc. is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The Company’s product, The Argus II Retinal Prosthesis System (Argus II) treats outer retinal degenerations, such as retinitis pigmentosa (RP).It restores functional vision for people suffering from blindness. The Argus II System is approved in the United States by the Food & Drug Administration (FDA) and European Economic Area (CE Mark) and is available in some European countries. As of November 14, 2014, the Company’s Argus II System was implanted in about 90 patients in the United States, Canada, France, Italy, Germany, the Netherlands, Saudi Arabia, Spain, Switzerland and the United Kingdom. The Company is also developing another product for cortical stimulation, known as the Orion I visual prosthesis, to treat nearly all forms of blindness.

Add a Topic
Add a Topic
Add a Topic
👍 11518
May 31, 2015 6:05 pm

EYES-upcoming presentation and webcast:
Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that the Company will present at the Three Part Advisors East Coast IDEAS Conference, as follows:

Presentation Date: Thursday, June 4, 2015
Presentation Time: 3:10 p.m. EDT
Location: Boston Park Plaza, Boston, MA

The presentation will be webcast live and can be accessed at the conference website, http://wsw.com/webcast/threepa16/eyes, or in the Investor Relations section of the Company’s website, secondsight.com. Best2ALL!-Benjamin

👍 11518
June 3, 2015 7:31 pm

EYES-7:00 am ET Second Sight Appoints Matthew J. Pfeffer to Its Board of Directors
BusinessWire SP has increased from the mid $11s in mid-May to $15.15 current. Best2ALL!-Benjamin

👍 11518

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info